aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Eclipse Diagnostics is a biotechnology company focused on developing next-generation diagnostic tools using proprietary testing technologies. Their mission is to provide innovative solutions for home and field testing, catering to consumers, industry, and law enforcement. The company aims to make advanced diagnostic capabilities accessible and convenient.
Eclipse Diagnostics has made significant strides in the biotech industry by introducing cutting-edge diagnostic tools that enhance accuracy and usability. Their impact is evident in the improved efficiency and reliability of testing processes across various sectors.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Diagnostics, Test Kits
Technology
Biotech
Tags
Healthtech
Model Types
Hardware, Software
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Consumers, Enterprise, Government
Geographic Exposure
Global
When was Eclipse Diagnostics founded?
Eclipse Diagnostics was founded in 2018.
Where is Eclipse Diagnostics’s headquarters located?
Eclipse Diagnostics’s headquarters is located in DE, US.
When was Eclipse Diagnostics’s last funding round?
Eclipse Diagnostics’s most recent funding round was for $179.1k (USD) in April 2020.
How many employees does Eclipse Diagnostics have?
Eclipse Diagnostics has 5 employees as of Feb 5, 2024.
How much has Eclipse Diagnostics raised to-date?
As of July 05, 2023, Eclipse Diagnostics has raised a total of $350.8k (USD) since Apr 30, 2020.
Add Comparison
Total Raised to Date
$350.8k
USD
Last Update Apr 30, 2020
Last Deal Details
$179.1k
USD
Apr 30, 2020
Equity Crowdfunding
Total Employees Over Time
5
As of Feb 2024
Eclipse Diagnostics Address
Delaware
United States of America
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts